Breast Cancer Clinical Trial

Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer

Summary

The goal of this clinical research study is to test if a short breast MRI scan (about 10 minutes) can be used for breast cancer screening in high risk people and to learn if it is as effective as a routine breast MRI scan (30-60 minutes).

View Full Description

Full Description

If you agree to take part in this study, you will have the short breast MRI scan (the scan for research purposes) with contrast on a different day than your scheduled routine MRI screening scan with contrast. You will have your routine scan the first day and the research scan at least 1 day after. The research scan will take about 10 minutes to complete.

After your short breast MRI scan is completed, you will complete a questionnaire about your comfort level and experience of the research scan. It should take about 10 minutes to complete the questionnaire.

This is an investigational study. The short breast MRI is considered investigational.

Up to 200 participants will be enrolled in this study. All will be enrolled at MD Anderson.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years and older female patients
BMRI indication: high risk screening per ACS guidelines
No contraindications to undergo MRI
Creatinine 40
No requirement for sedation.

Exclusion Criteria:

<18 years
Male
Is pregnant (confirmed by the patient as Imaging Clinic standard of care) or nursing mother
Contraindication to Gd contrast agents
Previous documented history of moderate to severe hypersensitivity to Gd contrast agents
Contraindications to MRI

Study is for people with:

Breast Cancer

Phase:

Early Phase 1

Estimated Enrollment:

131

Study ID:

NCT02590458

Recruitment Status:

Completed

Sponsor:

M.D. Anderson Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Texas MD Anderson Cancer Center
Houston Texas, 77030, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Early Phase 1

Estimated Enrollment:

131

Study ID:

NCT02590458

Recruitment Status:

Completed

Sponsor:


M.D. Anderson Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider